- All
- Acute kidney injury
- aHUS
- Alport syndrome
- Anaemia
- Andy Cole Fund
- BK virus
- Blog
- Blood pressure
- Calciphylaxis
- Cancer
- Case study
- Chronic kidney disease
- CMV
- Collaboration and partnerships
- Coronavirus
- Corporate partnership
- cystinosis
- Cystinuria
- Diabetes
- Dialysis
- Focal segmental glomerulosclerosis
- Fundraising
- Health Equalities
- Heart disease
- HUS
- Idiopathic nephrotic syndrome
- IgA nephropathy
- Kidney health
- Kidney rare diseases
- Kidney stones
- Lupus
- Mental health
- Nephrotic syndrome
- NURTuRE
- Paediatric
- Patient Stories
- Podcast
- Policy
- Polycystic kidney disease
- Research
- Transplantation
- Uncategorised
- Volunteering

Testing new therapies for children with autosomal recessive polycystic kidney disease
Professor David Long from University College London Great Ormond Street Institute of Child Health has received a Kidney Research UK paediatric and rare diseases research project grant of £200,000 to test new therapies for autosomal recessive polycystic kidney disease (ARPKD) that focuses on how cysts use energy. This project forms part of the PKD Partnership, led by Kidney Research UK and the PKD Charity. New treatments are…

Walking in memory of beloved mum 20 years after losing her to kidney disease
This July, 59-year-old Rachelle Temple will take part in the Kidney Research UK London Bridges Walk for the 19th time, in memory of her mum, Betty, who died 20 years ago from kidney disease. Rachelle, from Hockley in Essex, will be joined by several family members, including her daughters, Nicole and Jessica. She says: “They were only ten and eight when Mum died. Her grandchildren…

Vital funding allocated to kidney research
Kidney Research UK is set to receive almost £1m to expand the UK’s renal research capabilities by attracting and retaining more scientists and clinicians. The money, from the National Institute for Health and Care Research, is part of a new package of £37m funding being awarded to 89 medical research charities in the UK to support early career researchers. The funding will enable the charity to boost interest in working in renal…

SMC accepts sparsentan for adults living with IgA nephropathy in Scotland
Kidney Research UK has welcomed the Scottish Medicine Consortium’s acceptance of sparsentan (Filspari ®) for use in some adults in Scotland living with primary immunoglobulin A nephropathy (IgAN), published today. The SMC decision takes into account patient views gathered by Kidney Research UK through a focus group, and those expressed at a Patient and Clinician Engagement (PACE) meeting at which Kidney Research UK’s patient expert Mark Devlin talked about his lived experiences of the condition. “I would have loved to have had a treatment that would…

Undiagnosed chronic kidney disease endangers millions of lives
Millions of people worldwide are at risk because chronic kidney disease (CKD) is going undiagnosed, according to global research being unveiled this week. Former Kidney Research UK fellow, Dr Jennifer Lees has led an international collaboration on the research being published in The Lancet and shared at the European Renal Association conference in Glasgow. Their…





